|
|
6201 South Freeway Fort Worth, Texas 76134 USA phone:800-862-5266 fax:
|
|
| Symbol |
ACL |
| Exchange |
NYSE |
| Founded |
1945 |
| Employees |
2500 |
|
|
| www.alcon.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Ophthalmic pharmaceuticals, surgical equipment and devices, and other consumer eye care products. |
 |
| Management |
| Kevin J. Buehler, President and Chief Executive Officer; Bill Barton, Senior Vice President, International Markets; Richard Croarkin, Senior Vice President Finance, Chief Financial Officer and Corporate Strategy Officer; Sabri Markabi, M.D., Senior Vice President Research and Development and Chief Medical Officer; Ed McGough, Senior Vice President, Global Manufacturing and Technical Operations; Elaine E. Whitbeck, Senior Vice President, Chief Legal Officer, General Counsel and Corporate Secretary |
| |
|
|
|
|
|
|
|
| Keywords |
| allergies, eye diseases, advamed, eye care, eliminate blindness, eye health |
|
|
|
| Description |
|
Alcon, Inc. develops, manufactures and markets ophthalmic pharmaceuticals, ophthalmic surgical equipment and devices, contact lens care products and other consumer eye care products that treat diseases and conditions of the eye. With the exception of eye-glasses and contact lenses, they operate in all areas of ophthalmology. |
 |
 |
|
|
|
|
|
|